CUAMC
RARE icon

China Universal Asset Management Company’s Ultragenyx Pharmaceutical RARE Stock Holding History

China Universal Asset Management Company’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$523K Sell
15,675
-1,473
-9% -$36.6K 0.03% 260
2026
Q1 		$359K Buy
17,148
+1,427
+9% +$32.1K 0.03% 294
2025
Q4 		$362K Sell
15,721
-1,172
-7% -$38.5K 0.03% 286
2025
Q3 		$508K Sell
16,893
-2,095
-11% -$62.8K 0.04% 247
2025
Q2 		$690K Buy
18,988
+434
+2% +$15.6K 0.07% 216
2025
Q1 		$672K Sell
18,554
-1,026
-5% -$42.7K 0.06% 215
2024
Q4 		$824K Buy
19,580
+1,854
+10% +$92K 0.08% 188
2024
Q3 		$985K Buy
17,726
+7,960
+82% +$405K 0.11% 140
2024
Q2 		$401K Sell
9,766
-6,051
-38% -$258K 0.06% 166
2024
Q1 		$738K Buy
15,817
+6,316
+66% +$298K 0.09% 147
2023
Q4 		$454K Buy
9,501
+7,670
+419% +$297K 0.09% 151
2023
Q3 		$65.3K Buy
1,831
+903
+97% +$35.8K 0.02% 222
2023
Q2 		$42.8K Sell
928
-23
-2% -$1.07K 0.01% 207
2023
Q1 		$38.1K Buy
951
+239
+34% +$10.3K 0.01% 171
2022
Q4 		$33K Buy
712
+56
+9% +$2.2K 0.01% 153
2022
Q3 		$27K Buy
+656
New +$33.7K 0.01% 141

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

China Universal Asset Management Company's RARE Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Ultragenyx Pharmaceutical (RARE) stake by 8.6% in Q2 2026, selling an estimated $36.6K and leaving 15,675 shares worth $523K. The position accounts for 0.03% of the portfolio, ranked #260.

China Universal Asset Management Company first reported a position in RARE in Q3 2022 and has held it in 16 quarters since. The position peaked at $985K in Q3 2024. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • China Universal Asset Management Company held 15,675 shares of Ultragenyx Pharmaceutical worth $523K as of Q2 2026.
  • China Universal Asset Management Company sold 1,473 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $36.6K.
  • Ultragenyx Pharmaceutical made up 0.03% of China Universal Asset Management Company's portfolio in Q2 2026, its #260 holding.
  • China Universal Asset Management Company first reported a position in Ultragenyx Pharmaceutical in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Ultragenyx Pharmaceutical position peaked at $985K in Q3 2024.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.